Six-Year Real-World Outcomes of Antivascular Endothelial Growth Factor Monotherapy and Combination Therapy for Various Subtypes of Polypoidal Choroidal Vasculopathy
The purpose of this study was to compare 6-year visual outcomes of antivascular endothelial growth factor (anti-VEGF) monotherapy and initial combination therapy of photodynamic therapy (PDT) and anti-VEGF therapy for polypoidal choroidal vasculopathy (PCV) in a Chinese population and to investigate...
Saved in:
Main Authors: | Jingyuan Yang, Mingzhen Yuan, Song Xia, Youxin Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | Journal of Ophthalmology |
Online Access: | http://dx.doi.org/10.1155/2019/1609717 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Detection Rate and Diagnostic Value of Optical Coherence Tomography Angiography in the Diagnosis of Polypoidal Choroidal Vasculopathy: A Systematic Review and Meta-Analysis
by: Yuelin Wang, et al.
Published: (2019-01-01) -
The Efficacy of Conbercept in Polypoidal Choroidal Vasculopathy: A Systematic Review
by: Yimin Wang, et al.
Published: (2020-01-01) -
Verteporfin Photodynamic Therapy Combined with Intravitreal Ranibizumab for Polypoidal Choroidal Vasculopathy Controversy Concerning Long-Term Followup
by: Maribel Fernández, et al.
Published: (2012-01-01) -
Role of Intravitreal Antivascular Endothelial Growth Factor Injections for Choroidal Neovascularization due to Choroidal Osteoma
by: Ahmad M. Mansour, et al.
Published: (2014-01-01) -
Choroidal Vascularity Index as a Biomarker for Visual Response to Antivascular Endothelial Growth Factor Treatment in Diabetic Macular Edema
by: Ningxin Dou, et al.
Published: (2021-01-01)